← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 5, 2020Last known activity
Nov 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT06587945OfficialN/ANov 1, 2024
- NCT05275738CollaboratorN/AMay 18, 2022
- NCT04565756Overall official - principal investigatorPhase 1/Phase 2Nov 5, 2020
Details
- Last known activity
- Nov 1, 2024